In GBM, IDH mut and 1p/19q codeletion subsets present with low levels of MAP4K1 mRNA, implying that mutated IDH, particularly codeleted 1p/19q, may constrain MAP4K1 expression. Here, MAP4K1 is linked to glioblastoma.